Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126400831 | 12640083 | 1 | I | 20160726 | 20160803 | 20160810 | 20160810 | EXP | GB-MHRA-TPP6014817C1198998YC1469519258607 | GB-009507513-1608GBR002694 | MERCK | 71.00 | YR | M | Y | 82.00000 | KG | 20160810 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126400831 | 12640083 | 1 | PS | EZETIMIBE. | EZETIMIBE | 1 | U | U | 21445 | TABLET | |||||||||
| 126400831 | 12640083 | 2 | C | BETAHISTINE | BETAHISTINE | 1 | 126 | DF | 0 | 1 | DF | TID | |||||||
| 126400831 | 12640083 | 3 | C | BETAHISTINE | BETAHISTINE | 1 | APPLY FOR 10 DAYS | 126 | DF | 0 | 1 | DF | BID | ||||||
| 126400831 | 12640083 | 4 | C | BETAHISTINE | BETAHISTINE | 1 | 126 | DF | 0 | 1 | DF | QD | |||||||
| 126400831 | 12640083 | 5 | C | BETAHISTINE | BETAHISTINE | 1 | EACH NIGHT | 126 | DF | 0 | 1 | DF | QD | ||||||
| 126400831 | 12640083 | 6 | C | CLOBETASONE BUTYRATE | CLOBETASONE BUTYRATE | 1 | APPLY FOR 10 DAYS | 58 | DF | 0 | 1 | DF | BID | ||||||
| 126400831 | 12640083 | 7 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 1 DF, QD | 0 | 1 | DF | QD | ||||||||
| 126400831 | 12640083 | 8 | C | MINERAL OIL (+) PETROLATUM, WHITE | MINERAL OILPETROLATUM | 1 | APPLY FOR 4 WEEKS | 189 | DF | 0 | 1 | DF | CREAM | TID | |||||
| 126400831 | 12640083 | 9 | C | GAVISCON ADVANCE | POTASSIUM BICARBONATESODIUM ALGINATE | 1 | UP TO FOUR TIMES DAILY AFTER MEALS AND BEF... | 0 | 1 | DF | |||||||||
| 126400831 | 12640083 | 10 | C | LATANOPROST. | LATANOPROST | 1 | Other | ONE DROP TO BOTH EYES AT NIGHT. | 610 | Gtt | 0 | 2 | GTT | QD | |||||
| 126400831 | 12640083 | 11 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | TAKE ONE OR TWO FOUR TIMES A DAY. | 0 | TABLET | ||||||||||
| 126400831 | 12640083 | 12 | C | RANITIDINE. | RANITIDINE | 1 | EACH NIGHT, DOSAGE FORM | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126400831 | 12640083 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126400831 | 12640083 | Defaecation urgency | |
| 126400831 | 12640083 | Fatigue | |
| 126400831 | 12640083 | Gastrooesophageal reflux disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126400831 | 12640083 | 1 | 20160627 | 0 | ||
| 126400831 | 12640083 | 2 | 20160614 | 20160712 | 0 | |
| 126400831 | 12640083 | 3 | 20160503 | 20160531 | 0 | |
| 126400831 | 12640083 | 4 | 20150828 | 0 | ||
| 126400831 | 12640083 | 5 | 20160412 | 0 | ||
| 126400831 | 12640083 | 6 | 20160503 | 20160531 | 0 | |
| 126400831 | 12640083 | 7 | 20150828 | 0 | ||
| 126400831 | 12640083 | 8 | 20160524 | 20160525 | 0 | |
| 126400831 | 12640083 | 9 | 20130604 | 0 | ||
| 126400831 | 12640083 | 10 | 20150925 | 0 | ||
| 126400831 | 12640083 | 11 | 20160503 | 20160507 | 0 | |
| 126400831 | 12640083 | 12 | 20160421 | 0 |